# Exxel Pharma, INC. — Form D

Exxel Pharma, INC. of Aurora, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-02. The offering totals $600K, of which $600K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-12-02
- Form: D
- Accession: 0002046638-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $600K
- Amount sold: $600K
- Minimum investment: $125K
- Investors: 1
- Date of first sale: 2024-11-20
- Security types: debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-530836

## Issuer

- Name: Exxel Pharma, INC.
- CIK: 0002046638
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 12635 East Montview Blvd, Aurora, CO, 80045
- Phone: 720-261-1109

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Soren Mogelsvang | Director | Aurora, CO |
| Guy Yachin | Director | Aurora, CO |
| Soren Mogelsvang | Executive Officer | Aurora, CO |

## More

- [CIK 2046638 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2046638&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002046638-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.